University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 21 of 21
Integrating Palliative and Critical Care (IPACC) Study
NCT00685893
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
NCT00230477
Study of Aranesp to Treat Anemia in Prostate Cancer Patients.
NCT00245895
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
NCT00113685
Early Characteristics of Autism
NCT00090415
Caries Transmission Prevention in Alaska Native Infants
NCT00067340
Breath Ammonia Method for H. Pylori Detection: Phase II
NCT00194688
Middle School to High School Transition Project: Depression and Substance Abuse Prevention
NCT00071513
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons
NCT00161434
Effect of Leukoreduced Blood Transfusions on Infection Following Trauma
NCT00135291
Nursing Management of Irritable Bowel Syndrome:Improving Outcomes
NCT00167635
Suppression of Oral HHV8 Shedding With Valganciclovir
NCT00194467
Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
NCT00122096
Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)
NCT00101881
Therapy for Depressed Elders With Thought Problems
NCT00052091
Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer
NCT00283829
Carpal Tunnel Syndrome: Diagnosis and Treatment Trial
NCT00032227
Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home
NCT00194506
Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer
NCT00194727
Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
NCT00283803
Psychosocial/Behavioral Intervention in Post-Stroke Depression
NCT00194454
Short Course Nitrofurantoin for Acute Cystitis
NCT00391651
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12
NCT00194753
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
NCT00436254
Couples Miscarriage Healing Project:Randomized Trial
NCT00194844
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
NCT00715273
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
NCT00030563
Preventing Chronic Whiplash Pain
NCT00021476
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
NCT00041470
Alzheimer's in Long-Term Care--Treatment for Agitation
NCT00161473
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
NCT00194766
Preferred Treatment of Type 1.5 Diabetes
NCT00194896
A Trial of Point of Care Information in Ambulatory Pediatrics
NCT00368823
Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
NCT00194571
Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing
NCT00194441
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
NCT00005023
Study of NTBC for Tyrosinemia I
NCT00004443
Magnesium Sulfate For Brain Injury
NCT00004730
Tailored Treatments of Fibromyalgia
NCT00000422
"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
NCT00004640
Exercise to Improve Sleep in Heart Failure
NCT00194701
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
NCT00194740
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
NCT00223665
Health Effects of Silver-Mercury Dental Fillings
NCT00066118
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
NCT00003002
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
NCT00002746
Effectiveness of Pressure Garment Therapy After Burns
NCT01005732
Interleukin-2 in Treating Patients With Mycosis Fungoides
NCT00002687
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.